Glaxo piles on the pressure
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Glaxo piles on the pressure
Glaxo wrote to Wellcome shareholders yesterday reminding them of next Wednesday's first deadline for accepting its £9bn takeover bid, pitched at 1,033p per share.
The letter said that despite Wellcome's search for a better offer Glaxo's bid was still the only one on the table and pointed to the fact that Wellcome's share price still stood at a discount to the value of the bid. Wellcome responded with its own letter advising shareholders to take no action and gave its strongest hint yet that it may be close to finding a "white kni
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments